Adam Feuerstein ✡️ — $NKTR reporting 52-week rezpeg results in alopecia areata.
Bottom line: 27% of participants treated with low or high dose of rezpeg achieved a clinically meaningful hair-growth o…↗
Adam Feuerstein ✡️ — @Biohazard3737 I put together a Q4 list, fairly active heading into end of year, which is nice. Will post it later in the week.
$INSM $NKTR $GPCR $CYTK among others↗
Sep 18
KawzInvests 🦑 — How $NKTR was looking at me today https://t.co/Ox9vU2CQ1k↗
Adam Feuerstein ✡️ — $NKTR here we go! Rezpeg maintenance data in atopic dermatitis. The big picture:
71% of patients on monthly rezpeg maintained their induction EASI75 response at one year.
83% of p…↗
Feb 5
Adam Feuerstein ✡️ — In this week's Biotech Scorecard newsletter:
-- A preview of the $NKTR rezpeg maintenance data in atopic dermatitis. I also chatted with CEO Howard Robin during JPM Week.
-- A d…↗
Feb 5
Adam Feuerstein ✡️ — Nektar Therapeutics $NKTR is trying to stage a comeback. But a big test awaits
https://t.co/5bKmgSnx9R↗